EE175 Cost Effectiveness of Empagliflozin vs. Ertugliflozin in Patients with Type-2 Diabetes
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.424
https://www.valueinhealthjournal.com/article/S1098-3015(22)00625-8/fulltext
Title :
EE175 Cost Effectiveness of Empagliflozin vs. Ertugliflozin in Patients with Type-2 Diabetes
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00625-8&doi=10.1016/j.jval.2022.04.424
First page :
Section Title :
Open access? :
No
Section Order :
10369